Evotec (NASDAQ:EVO) Shares Gap Up to $7.45

Evotec SE (NASDAQ:EVO)’s stock price gapped up prior to trading on Wednesday . The stock had previously closed at $7.45, but opened at $7.67. Evotec shares last traded at $7.73, with a volume of 8,796 shares changing hands.

Wall Street Analysts Forecast Growth

Separately, Royal Bank of Canada upgraded Evotec from a “sector perform” rating to an “outperform” rating in a report on Thursday, January 18th.

Evotec Stock Up 0.3 %

The business has a fifty day moving average price of $7.48 and a 200 day moving average price of $9.11.

Institutional Trading of Evotec

A number of institutional investors have recently modified their holdings of the company. Quadrant Capital Group LLC bought a new stake in Evotec during the fourth quarter worth about $25,000. OLD Mission Capital LLC bought a new stake in Evotec during the fourth quarter worth about $141,000. Optiver Holding B.V. raised its holdings in Evotec by 643.1% during the fourth quarter. Optiver Holding B.V. now owns 80,810 shares of the company’s stock worth $945,000 after acquiring an additional 69,936 shares in the last quarter. Finally, Mubadala Investment Co PJSC bought a new stake in Evotec during the fourth quarter worth about $53,931,000. 5.81% of the stock is currently owned by institutional investors.

Evotec Company Profile

Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare diseases, respiratory diseases, and women's health.